CONNECTA Therapeutics has started a Phase 2a clinical trial of [...]

Lario Therapeutics awarded $2.4M by The Michael J. Fox Foundation [...]

Exciva GmbH has raised €51 million ($59m) in a Series [...]

Neuraxpharm and mjn-neuro are preparing to launch a digital health [...]

Neuraxpharm Group has launched Riulvy (tegomil fumarate) in Germany, marking [...]

Barcelona-based biotech advances Huntington’s programme as EMA backs orphan designation, [...]

An investigational prescription digital therapeutic (PDT) designed to treat negative [...]

Neuraxpharm Group, a leading European specialty pharmaceutical company focused on [...]

New approach targets Elk1 to restore neuroplasticity without sedation or [...]

Vesper Bio has reached a key enrolment milestone in its [...]